Kendamil incurs ad watchdog wrath over formula health claims

By Will Chu

- Last updated on GMT

Kendamil incurs ad watchdog wrath over formula health claims

Related tags Kendamil Asa Formula milk

Baby formula manufacturer Kendamil has fallen foul of UK advertising guidelines after content on its website appeared to discourage breastfeeding and prevent and treat colic and constipation in babies.

Complaints, including one from the British Specialist Nutrition Association (BSNA), also objected to the series of reviews that confused infant formula with follow-on formula as well as making health claims for Kendamil products.

In response Kendamil said quotes contained in the ad had been automatically pulled from consumer reviews left on Facebook and other third-party websites and integrated into their website. As a result, they did not have any editorial control over the contents of those reviews.

They added they did not believe the claim “benefit my daughter the way breastmilk had”​ discouraged breastfeeding stating that the claim was ‘intended to mean that the formulas they produced were the closest to breastfeeding.’

The Kendal-based firm added that they had provided evidence substantiating the claims “benefit my daughter the way breastmilk had,” “great for her development,” and “colic and constipation … stopped straightaway…”.

They did not think the claims made confused infant formula with follow-on formula.

ASA evaluation

In its assessment, ASA acknowledged Kendamil’s comments about a lack of editorial control but pointed out that third-party reviews were user-generated content that had been adopted and incorporated into Kendamil’s own website.

“We considered that the website was under Kendamil’s control and was directly connected with the supply of goods through their online shop,”​ the Authority added. “The website and its contents were therefore an ad for the purposes of the Code.”

Regarding the confusion between infant and follow-on formula ASA thought that consumers would understand the statement “… my son is 9 months old & been on it since birth”​ to mean the ad was promoting Kendamil’s infant formula.

“We further considered that the babies featured were not clearly identifiable as being over the age of six months and that contributed to the impression that it was an ad for infant formula. We therefore considered that the ad had the effect of marketing infant formula.”

ASA also added the lack of clarity in the reviews caused ambiguity as to whether the ad was referring to infant or follow-on formulas.

“Because the ad had the effect of marketing infant formula, which was prohibited under the Code, and because it confused between infant and follow-on formulas, which was also prohibited under the Code, we concluded that it had breached the Code,”​ ASA said

‘Prevent, treat or cure human disease’

The Code had also been breached with the claims “benefit my daughter the way breastmilk had”​ and “great for her development,” ​according to ASA, who considered that consumers would understand those claims, when taken alongside the images of a child who appeared to be under six months old, as referring to infant formula.

Also prohibited were claims which stated or implied a food could prevent, treat or cure human disease were prohibited for foods; that requirement also applied to infant and follow-on formulas.

“We considered that consumers would understand from the claim “colic and constipation … stopped straightaway”​ that using Kendamil’s products could prevent and treat colic and constipation in babies.

“We therefore considered the ad made disease treatment claims for a food and concluded that it breached the Code.”

The ad must not appear again in the form complained about. We told Kendamil to ensure that their future marketing communications did not refer, either implicitly or explicitly, to infant formula and did not confuse between infant and follow-on formulas.

“[Marketing communications must not] make claims or statements that discouraged breastfeeding; make health or nutrition claims for infant formula; and state or imply that a food could prevent, treat, or cure human disease.”

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

4 reasons children need MFGM, according to science

4 reasons children need MFGM, according to science

Content provided by Valio | 29-Sep-2023 | White Paper

In this white paper, Dr Anu Turpeinen discusses the ample scientific evidence showing why milk fat globule membrane (MFGM) is essential for children’s...

An Insights-driven Holistic Approach to Health

An Insights-driven Holistic Approach to Health

Content provided by Lipofoods, a Lubrizol Company | 25-Sep-2023 | Product Brochure

As they adopt the notion of holistic health, proactive consumers are driving the demand for products that have science-backed ingredients and offer sensory...

Related suppliers

Follow us

Products

View more

Webinars